Edwards Lifesciences Corporation (EW) Q1 2024 Earnings Call Transcript

Edwards Lifesciences Corporation (NYSE:EW) Q1 2024 Earnings Conference Call April 25, 2024 5:00 PM ET

Company Participants

Mark Wilterding – SVP & IR
Bernard Zovighian – CEO
Scott Ullem – CFO
Daveen Chopra – Global Leader of TMTT
Larry Wood – Group President of TAVR and Surgical Structural Heart
Katie Szyman – Global Leader of Critical Care

Conference Call Participants

Robbie Marcus – JPMorgan
Travis Steed – Bank of America
Larry Biegelsen – Wells Fargo
Matt Taylor – Jefferies
Joanne Wuensch – Citi
Matt Miksic – Barclays
Shagun Singh – RBC Capital Markets
Chris Pasquale – Nephron Research
Philip Chickering – Deutsche Bank
Richard Newitter – Truist Securities
Danielle Antalffy – UBS
Joshua Jennings – TD Cowen

Operator

Greetings, and welcome to the Edwards Lifesciences First Quarter 2024 Results. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Mark Wilterding, Senior Vice President, Investor Relations. Thank you, you may begin.

Mark Wilterding

Thanks a lot, Diego, and good afternoon, and thank you all for joining us. With me on today’s call is our CEO, Bernard Zovighian, and our CFO, Scott Ullem. Also joining us for the Q&A portion of the call will be Larry Wood, our Global President of TAVR and Surgical Structural Heart; Daveen Chopra, our Global Leader of TMTT; Wayne Markowitz, our Global Leader of Surgical Structural Heart; and Katie Syzman, our Global Leader of Critical Care.

Just after the close of regular trading, Edwards Lifesciences released first quarter 2024 financial results. During today’s call, management will discuss these results included in the press release and accompanying financial schedules and then use the remaining time for Q&A. Please note that management will be

Read the full article here